DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
Titel:
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
Auteur:
Gupta, A. Love, S. Schuh, A. Shanyinde, M. Larkin, J.M. Plummer, R. Nathan, P.D. Danson, S. Ottensmeier, C.H. Lorigan, P. Collins, L. Wise, A. Asher, R. Lisle, R. Middleton, M.R.